Prior Authorization Leads to Radiation Oncology Treatment Delays, Patient Harm
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 9, 2024 -- Prior authorization delays lead to serious harm for people with cancer, according to a survey conducted by the American Society for Radiation Oncology (ASTRO).
The survey, conducted in the fall of 2024, included responses from 754 physicians from across the United States, representing both academic (47 percent) and private (51 percent) practices in different types of communities (49 percent urban; 39 percent suburban; 13 percent rural).
According to the results of the survey, nearly one-third of respondents (30 percent) say prior authorization has caused adverse events, including emergency room visits, hospitalization, or permanent disability for their patients, with 7 percent reporting that it has led or contributed to the death of a patient in their care. Almost all radiation oncologists (92 percent) say that prior authorization causes treatment delays, which are experienced by more than one-third of their patients (35 percent). One-third of physicians say prior authorization has led to approximately one in 10 patients abandoning radiation treatment. Most physicians (58 percent) say prior authorization left them unable to adhere to established guidelines, and 82 percent say prior authorization has forced them to resort to a less optimal treatment than they originally prescribed. More than nine in 10 radiation oncologists agree that prior authorization either significantly or somewhat worsens staff burnout in their clinics, with eight in 10 doctors saying the prior authorization burden has grown worse in the past three years.
"These survey findings confirm what radiation oncologists witness daily: prior authorization policies are failing people with cancer, causing avoidable delays that are dangerous and, in too many cases, deadly," Howard M. Sandler, M.D., chair of the ASTRO Board of Directors, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study...
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus...
ENDO: 1999 to 2020 Saw Significant Uptick in Obesity-Related Cancer Deaths
MONDAY, July 14, 2025 -- From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.